MIST: Milestone Pharmaceuticals Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-07 | New 13G stake | Pavaki Capital Management LLC | 7.30% | SEC |
Institutional ownership (Q2 2026)
78 institutions reported holding $68.01M of Milestone Pharmaceuticals Inc. on Form 13F (87 the quarter before). 6 opened a new position and 13 sold out. Shares held by institutions: +29%.
| Largest holders | Shares | Value |
|---|---|---|
| Pavaki Capital Management LLC | 9,067,848 | $12.15M |
| RTW INVESTMENTS, LP | 7,833,336 | $10.50M |
| Propel Bio Management, LLC | 7,429,590 | $9.96M |
| Point72 Asset Management, L.P. | 5,411,138 | $7.25M |
| Simplify Asset Management Inc. | 3,349,379 | $4.49M |
| MILLENNIUM MANAGEMENT LLC | 3,142,219 | $4.21M |
| Kalehua Capital Management LLC | 2,538,474 | $3.40M |
| TWO SIGMA INVESTMENTS, LP | 2,040,015 | $2.73M |
| MARSHALL WACE, LLP | 1,797,695 | $2.41M |
| Lion Point Capital, LP | 820,000 | $1.10M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.